| GTO ID | GTC1483 |
| Trial ID | NCT02159716 |
| Disease | Epithelial Ovarian Cancer | Malignant Pleural Mesothelioma | Pancreatic Adenocarcinoma |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MESO CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | CART-meso in Mesothelin Expressing Cancers |
| Year | 2014 |
| Country | United States |
| Company sponsor | University of Pennsylvania |
| Other ID(s) | UPCC 31213, 819826 |
| Vector information | |||||
|
|||||
| Cohort1: dose level 1 | |||||||
|
|||||||
| Cohort2: dose level 2 | |||||||
|
|||||||